Terminalia chebula Polyphenol and Near-Infrared Dye-Loaded Poly(lactic acid) Nanoparticles for Imaging and Photothermal Therapy of Cancer Cells
Photothermal/photodynamic therapies (PTT/PDT) are multimodal approaches employing
near-infrared (NIR) light-responsive photosensitizers for cancer treatment. In the current …
near-infrared (NIR) light-responsive photosensitizers for cancer treatment. In the current …
[HTML][HTML] Overview of the Anticancer Potential of the “King of Spices” Piper nigrum and Its Main Constituent Piperine
The main limits of current anticancer therapy are relapses, chemoresistance, and toxic
effects resulting from its poor selectivity towards cancer cells that severely impair a patient's …
effects resulting from its poor selectivity towards cancer cells that severely impair a patient's …
[HTML][HTML] Rhus coriaria L. (Sumac) Demonstrates Oncostatic Activity in the Therapeutic and Preventive Model of Breast Carcinoma
Comprehensive scientific data provide evidence that isolated phytochemicals or whole plant
foods may beneficially modify carcinogenesis. The aim of this study was to evaluate the …
foods may beneficially modify carcinogenesis. The aim of this study was to evaluate the …
Myricetin (3, 3′, 4′, 5, 5′, 7-Hexahydroxyflavone) Prevents 5-Fluorouracil-Induced Cardiotoxicity
5-Fluorouracil (5-FU) is a strong anti-cancer drug used to manage numerous cancers.
Cardiotoxicity, renal toxicity, and liver toxicity are some of the adverse effects which confine …
Cardiotoxicity, renal toxicity, and liver toxicity are some of the adverse effects which confine …
[HTML][HTML] Polymeric nanoparticles: Exploring the current drug development and therapeutic insight of breast cancer treatment and recommendations
This manuscript aims to provide the latest update on polymeric nanoparticle drug delivery
system for breast cancer treatment after 2015 and how research-oriented it is based on the …
system for breast cancer treatment after 2015 and how research-oriented it is based on the …
[HTML][HTML] Lipid-based nanoparticles in delivering bioactive compounds for improving therapeutic efficacy
P Patel, K Garala, S Singh, BG Prajapati… - Pharmaceuticals, 2024 - mdpi.com
In recent years, due to their distinctive and adaptable therapeutic effects, many natural
bioactive compounds have been commonly used to treat diseases. Their limited solubility …
bioactive compounds have been commonly used to treat diseases. Their limited solubility …
[HTML][HTML] Anticancer Properties of Plectranthus ornatus-Derived Phytochemicals Inducing Apoptosis via Mitochondrial Pathway
P Sitarek, E Synowiec, T Kowalczyk, G Bangay… - International Journal of …, 2022 - mdpi.com
Since cancer treatment by radio-and chemotherapy has been linked to safety concerns,
there is a need for new and alternative anticancer drugs; as such, compounds isolated from …
there is a need for new and alternative anticancer drugs; as such, compounds isolated from …
[HTML][HTML] Flavonoids as promising molecules in the cancer therapy: An insight
Cancer continues to increase global morbidity and mortality rates. Despite substantial
progress in the development of various chemically synthesized anti-cancer drugs, the poor …
progress in the development of various chemically synthesized anti-cancer drugs, the poor …
Augmentation of anti-proliferative efficacy of quercetin encapsulated chitosan nanoparticles by induction of cell death via mitochondrial membrane permeabilization in …
Quercetin (QCT), an antioxidant plant flavonoid, is known to impart prominent anti-cancer
properties. However, its clinical application as a potential drug is hindered owing to its …
properties. However, its clinical application as a potential drug is hindered owing to its …
Berberine—A potent chemosensitizer and chemoprotector to conventional cancer therapies
Chemotherapy and radiotherapy are mainstay treatments for cancer patients. However, their
clinical outcomes are highly limited by the resistance of malignant tumors to these therapies …
clinical outcomes are highly limited by the resistance of malignant tumors to these therapies …